David Cipolla

Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial

David J. Serisier, Diana Bilton, Anthony De Soyza et al. · Thorax · 2013 · 243 citations · Full text

Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system☆

Pradipta Chattopadhyay, Boris Y. Shekunov, DaBin Yim et al. · Advanced Drug Delivery Reviews · 2007 · 221 citations

Lipid Preparation, Aerx System☆, Pulmonary Delivery +5

Liposomal Nanoparticles Control the Uptake of Ciprofloxacin Across Respiratory Epithelia

Hui Xin Ong, Daniela Traini, David Cipolla et al. · Pharmaceutical Research · 2012 · 80 citations

Cell-based Drug Delivery, Nanomedicine, Nanotherapeutics +6

Modifying the Release Properties of Liposomes Toward Personalized Medicine

David Cipolla, Huiying Wu, Igor Gonda et al. · Journal of Pharmaceutical Sciences · 2014 · 70 citations

Ciprofloxacin nanocrystals liposomal powders for controlled drug release via inhalation

Isra Khatib, Dipesh Khanal, Juanfang Ruan et al. · International Journal of Pharmaceutics · 2019 · 68 citations

Nanoparticles, Nanomedicine, Engineering +5